Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 31.38% is 13% above its 5-year average of 27.87%, around the middle of its 5-year range (19.54%–37.55%).
6.52% below its 12-month average of 33.57%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 37.13%.
EBITDA MARGIN
31.38%
EBITDA MARGIN AVG TTM
33.57%
EBITDA MARGIN AVG 3Y
29.20%
EBITDA MARGIN AVG 5Y
27.87%
EBITDA MARGIN AVG 10Y
26.54%
EBITDA MARGIN AVG 15Y
22.32%
EBITDA MARGIN AVG 20Y
18.26%
CURRENT VS TTM AVG
-6.52%
CURRENT VS 3Y AVG
+7.47%
CURRENT VS 5Y AVG
+12.61%
CURRENT VS 10Y AVG
+18.25%
CURRENT VS 15Y AVG
+40.57%
CURRENT VS 20Y AVG
+71.89%
LeMaitre Vascular, Inc.
Market Cap
$1.82B
EBITDA Margin
31.38%
TTM Avg
33.57%
3Y Avg
29.20%
5Y Avg
27.87%
Market Cap
$1.85B
EBITDA Margin
-4034.86%
TTM Avg
-3070.57%
3Y Avg
-2386.79%
5Y Avg
-1872.66%
Market Cap
$1.79B
EBITDA Margin
-695.72%
TTM Avg
-791.65%
3Y Avg
-791.65%
5Y Avg
-791.65%
Market Cap
$1.89B
EBITDA Margin
3.75%
TTM Avg
2.81%
3Y Avg
-0.66%
5Y Avg
-2.07%
Market Cap
$1.91B
EBITDA Margin
-864.28%
TTM Avg
-1007.63%
3Y Avg
-1530.50%
5Y Avg
-1530.50%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LeMaitre Vascular, Inc. (LMAT) | $1.82B | 31.38% | 33.57% | 29.20% | 27.87% |
| Novocure Ltd (NVCR)vs › | $1.83B | -20.84% | -23.57% | -26.35% | -17.29% |
| Absci Corporation (ABSI)vs › | $1.85B | -4034.86% | -3070.57% | -2386.79% | -1872.66% |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 3.91% | 4.83% | 6.92% | 8.21% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.79B | -695.72% | -791.65% | -791.65% | -791.65% |
| Azenta, Inc. (AZTA)vs › | $1.87B | 8.41% | 9.50% | 6.21% | 7.73% |
| Novavax, Inc. (NVAX)vs › | $1.88B | 52.59% | 11.61% | -27.43% | -466.07% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 3.75% | 2.81% | -0.66% | -2.07% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.91B | -864.28% | -1007.63% | -1530.50% | -1530.50% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | -628.14% | -766.74% | -948.44% | -801.32% |
Gross Margin
72.9%
EBITDA Margin
31.4%
Operating Margin
29.5%
Net Margin
25.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 37.13% |
| 2026-03-31 | 30.65% |
| 2025-12-31 | 33.26% |
| 2025-09-30 | 37.55% |
| 2025-06-30 | 29.25% |
| 2025-03-31 | 25.35% |
| 2024-12-31 | 27.52% |
| 2024-09-30 | 28.41% |
| 2024-06-30 | 30.02% |
| 2024-03-30 | 26.66% |
| 2023-12-31 | 25.88% |
| 2023-09-30 | 24.41% |
| 2023-06-30 | 23.50% |
| 2023-03-31 | 21.72% |
| 2022-12-31 | 22.60% |
| 2022-09-30 | 21.72% |
| 2022-06-30 | 19.54% |
| 2022-03-31 | 26.04% |
| 2021-12-31 | 28.31% |
| 2021-09-30 | 31.27% |
| 2021-06-30 | 34.37% |
| 2021-03-31 | 29.45% |
| 2020-12-31 | 32.17% |
| 2020-09-30 | 34.88% |
| 2020-06-30 | 26.20% |
| 2020-03-31 | 19.28% |
| 2019-12-31 | 21.11% |
| 2019-09-30 | 24.91% |
| 2019-06-30 | 24.63% |
| 2019-03-31 | 20.08% |
| 2018-12-31 | 29.62% |
| 2018-09-30 | 23.25% |
| 2018-06-30 | 46.66% |
| 2018-03-31 | 22.69% |
| 2017-12-31 | 28.34% |
| 2017-09-30 | 24.40% |
| 2017-06-30 | 25.31% |
| 2017-03-31 | 21.43% |
| 2016-12-31 | 20.79% |
| 2016-09-30 | 26.66% |
| 2016-06-30 | 21.05% |
| 2016-03-31 | 20.64% |
| 2015-12-31 | 19.46% |
| 2015-09-30 | 21.79% |
| 2015-06-30 | 18.26% |
| 2015-03-31 | 16.58% |
| 2014-12-31 | 19.54% |
| 2014-09-30 | 15.16% |
| 2014-06-30 | 15.25% |
| 2014-03-31 | 3.58% |
| 2013-12-31 | 11.11% |
| 2013-09-30 | 9.80% |
| 2013-06-30 | 13.09% |
| 2013-03-31 | 11.27% |
| 2012-12-31 | 10.34% |
| 2012-09-30 | 11.21% |
| 2012-06-30 | 14.01% |
| 2012-03-31 | 10.07% |
| 2011-12-31 | 10.46% |
| 2011-09-30 | 17.21% |
| 2011-06-30 | 9.17% |
| 2011-03-31 | 2.95% |
| 2010-12-31 | -6.42% |
| 2010-09-30 | 17.18% |
| 2010-06-30 | 16.63% |
| 2010-03-31 | 11.70% |
| 2009-12-31 | 11.76% |
| 2009-09-30 | 12.36% |
| 2009-06-30 | 10.84% |
| 2009-03-31 | -11.00% |
| 2008-12-31 | 5.55% |
| 2008-09-30 | 4.34% |
| 2008-06-30 | -2.86% |
| 2008-03-31 | -18.29% |
| 2007-12-31 | -6.52% |
| 2007-09-30 | -13.08% |
| 2007-06-30 | -1.79% |
| 2007-03-31 | -6.60% |
| 2006-12-31 | -1.26% |
| 2006-09-30 | 7.66% |
| 2006-06-30 | -8.41% |
| 2006-03-31 | 9.59% |
| 2005-12-31 | -272.11% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | -275.72% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
